Literature DB >> 34257490

Prognostic Value of Right Ventricular Cardiac Power Output at Rest in Patients with Advanced Heart Failure.

Omer Yildiz1, Cemal Deniz Yenigun2.   

Abstract

BACKGROUND: There is supporting evidence that normal right heart function is crucial for the maintenance of normal overall hemodynamics. The heart can be described as a hydraulic pump, and cardiac power reflects the hydraulic function of the heart. The present analysis aimed to evaluate the prognostic value of right ventricular cardiac power output (RV-CPO) at rest in patients with advanced heart failure (HF).
METHODS: Between September 2010 and July 2013, 172 patients with advanced HF referred to our hospital were included in this study. Performing right-sided and left-sided heart catheterization simultaneously for each patient at baseline, we evaluated the hemodynamics with longitudinal follow-up of adverse outcomes such as cardiac mortality, ventricular assist device placement, and cardiac transplant (HTx).
RESULTS: The threshold RV-CPO at rest value was 0.15 Watts. Increased RV-CPO (> 0.15 Watts) was correlated with an increase in adverse outcomes. Over 52 months, we observed 50 cardiac deaths, 10 HTx, and 12 ventricular assist device placements. The prognostic value of RV-CPO remained significant after adjustment for age, gender, ejection fraction, cardiac output, mean arterial pressure, valvular heart disease, diabetes, body surface area and mineralocorticoid receptor antagonist medication dummy (hazard ratio 0.052, 95% confidence interval 0.006 to 0.406, p = 0.005).
CONCLUSIONS: Higher RV-CPO at rest was an independent predictor of adverse outcomes. Therefore, RV-CPO could be integrated into the clinical evaluation used for individual risk stratification of patients with advanced HF in order to consider earlier HTx listing and/or earlier consideration for mechanical circulatory support device therapy.

Entities:  

Keywords:  Heart failure; Mortality; Prognosis; Right ventricular cardiac power output

Year:  2021        PMID: 34257490      PMCID: PMC8261703          DOI: 10.6515/ACS.202107_37(4).20210123A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  16 in total

1.  Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.

Authors:  A Gavazzi; C Berzuini; C Campana; C Inserra; M Ponzetta; R Sebastiani; S Ghio; F Recusani
Journal:  J Heart Lung Transplant       Date:  1997-07       Impact factor: 10.247

2.  Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.

Authors:  Rebecca T Hahn; Theodore Abraham; Mark S Adams; Charles J Bruce; Kathryn E Glas; Roberto M Lang; Scott T Reeves; Jack S Shanewise; Samuel C Siu; William Stewart; Michael H Picard
Journal:  J Am Soc Echocardiogr       Date:  2013-09       Impact factor: 5.251

3.  Evaluation of Resting Cardiac Power Output as a Prognostic Factor in Patients with Advanced Heart Failure.

Authors:  Omer Yildiz; Gamze Aslan; Zumrut T Demirozu; Cemal Deniz Yenigun; Nuran Yazicioglu
Journal:  Am J Cardiol       Date:  2017-06-28       Impact factor: 2.778

Review 4.  Pulmonary hypertension due to left heart disease.

Authors:  Marco Guazzi; Barry A Borlaug
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

5.  Prognostic role of cardiac power index in ambulatory patients with advanced heart failure.

Authors:  Justin L Grodin; Wilfried Mullens; Matthias Dupont; Yuping Wu; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2015-04-28       Impact factor: 15.534

6.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.

Authors:  T G Di Salvo; M Mathier; M J Semigran; G W Dec
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

7.  Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure.

Authors:  Juan F Delgado; Esther Conde; Violeta Sánchez; Fernando López-Ríos; Miguel A Gómez-Sánchez; Pilar Escribano; Teresa Sotelo; Agustín Gómez de la Cámara; José Cortina; Carlos S de la Calzada
Journal:  Eur J Heart Fail       Date:  2005-10       Impact factor: 15.534

Review 8.  Pulmonary hypertension due to left heart disease.

Authors:  Emmanuelle Berthelot; Minh Tam Bailly; Safwane El Hatimi; Ingrid Robard; Hatem Rezgui; Amir Bouchachi; David Montani; Olivier Sitbon; Denis Chemla; Patrick Assayag
Journal:  Arch Cardiovasc Dis       Date:  2017-04-12       Impact factor: 2.340

9.  Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates.

Authors:  J R Wilson; G Rayos; T K Yeoh; P Gothard
Journal:  J Am Coll Cardiol       Date:  1995-08       Impact factor: 24.094

10.  Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study.

Authors:  Patric Karlström; Peter Johansson; Ulf Dahlström; Kurt Boman; Urban Alehagen
Journal:  BMC Cardiovasc Disord       Date:  2016-02-13       Impact factor: 2.298

View more
  1 in total

1.  Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.

Authors:  Rebecca R Vanderpool; Anastasia Gorelova; Yiran Ma; Mohammad Alhamaydeh; Jeffrey Baust; Sruti Shiva; Stevan P Tofovic; Jian Hu; Seyed Mehdi Nouraie; Mark T Gladwin; Maryam Sharifi-Sanjani; Imad Al Ghouleh
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.